MediciNova
MNOV
55 hedge funds and large institutions have $71.3M invested in MediciNova in 2018 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 17 reducing their positions, and 8 closing their positions.
25% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 8
4% more funds holding
Funds holding: 53 → 55 (+2)
6% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 17
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.27% less ownership
Funds ownership: 23.05% → 21.78% (-1.3%)
26% less capital invested
Capital invested by funds: $96.5M → $71.3M (-$25.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$2.3M |
| 2 |
VEA
Virtus ETF Advisers
New York
|
+$969K |
| 3 |
D.E. Shaw & Co
New York
|
+$755K |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$737K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$693K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$6.45M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.28M |
| 3 |
CM
Crestline Management
Fort Worth,
Texas
|
-$1.01M |
| 4 |
Jane Street
New York
|
-$860K |
| 5 |
Renaissance Technologies
New York
|
-$666K |
MNOV Hedge Fund Activity: Q2 2018 in Review
55 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q2 2018, worth a combined $71.3M — down 26% from $96.5M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new MNOV positions and 8 closed out — a net gain of 2 holders — while 18 added to existing stakes and 17 trimmed.
The largest buyer was BlackRock, adding an estimated $2.3M. The largest seller was Sphera Funds Management, exiting entirely with an estimated $6.45M sold.
- 55 institutional investors held MediciNova (MNOV) as of Q2 2018, up from 53 in Q1 2018.
- Funds reported $71.3M of MediciNova stock for Q2 2018, down 26% quarter-over-quarter.
- 10 funds opened new MediciNova positions in Q2 2018 and 8 closed out, a net change of +2 holders.
- The largest MediciNova buyer in Q2 2018 was BlackRock, an estimated $2.3M added.
- The largest MediciNova seller in Q2 2018 was Sphera Funds Management, an estimated $6.45M sold.
Based on aggregated 13F filings for Q2 2018.